ArticleMedComm2024

Patient-reported outcome and survival in premenopausal hormone receptor-positive breast cancer patients at moderate to high risk: comparing toremifene with aromatase inhibitor in a real-world study.

Yaping Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.